Achieve Life Sciences (ACHV) investor relations material

Opening remarks and agenda

• The meeting was called to order by the CEO and Chairperson, with the Chief Legal Officer acting as Secretary and the meeting being recorded.

• Stockholders were informed about voting procedures and the opportunity to change votes during the meeting.

• The agenda included the election of directors, ratification of the auditor, advisory vote on executive compensation, and an amendment to increase authorized shares.

Board and executive committee updates

• Director nominees were introduced, including individuals with recent appointments and diverse industry backgrounds.

• The board includes executives from various biopharmaceutical and investment firms, with several new directors appointed in 2025 and 2026.

• The Inspector of Elections and representatives from the independent auditor and election services were present.

Shareholder proposals

• Proposals included electing nine directors, ratifying the independent auditor, approving executive compensation, and amending the certificate of incorporation to increase authorized shares.

• Each proposal required a majority or plurality of votes properly cast at the meeting.